Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells-Reference-Cited by-同舟云学术

Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells

Published:2022-06-01 Issue:7 Volume:19 Page:2175-2182
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ferraresso Francesca¹,Strilchuk Amy W.¹,Juang Lih Jiin¹,Poole Lauren G.²,Luyendyk James P.²,Kastrup Christian J.¹³⁴^ORCID

Affiliation:

1. Michael Smith Laboratories and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada

2. Department of Pathobiology and Diagnostic Investigation, Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan 48823, United States

3. Blood Research Institute, Versiti, Milwaukee, Wisconsin 53226, United States

4. Departments of Surgery, Biochemistry, Biomedical Engineering, and Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States

Funder

Canadian Institutes of Health Research

National Institute of Diabetes and Digestive and Kidney Diseases

Natural Sciences and Engineering Research Council of Canada

BC Knowledge Development Fund

Canadian Venous Thromboembolism Clinical Trials and Outcomes Research

Nanomedicines Innovation Network of the Networks of Centres of Excellence

Canadian Foundation for Innovation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine